share_log

8-K: Current report

8-K: Current report

8-K:重大事件
美股SEC公告 ·  05/31 04:36

牛牛AI助理已提取核心訊息

On May 29, 2024, Nukkleus Inc., a company listed on the Nasdaq Stock Market, received a notification from Nasdaq's Listing Qualifications Department for non-compliance with the exchange's Listing Rule 5250(c)(1). The non-compliance issue arose due to Nukkleus Inc.'s failure to file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2024, in a timely manner. This notification is part of a series of warnings regarding the company's failure to meet certain listing requirements, including the Minimum Bid Price, Minimum Market Value of Publicly Held Shares, and Minimum Market Value of Listed Securities. Nukkleus Inc. has been given until July 29, 2024, to submit a compliance plan to Nasdaq and may receive an extension until November 11, 2024, to demonstrate compliance. The company is actively working to file the overdue Form 10-Q and regain compliance. Despite these notifications, the trading of Nukkleus Inc.'s common stock on the Nasdaq Global Market remains unaffected at this time.
On May 29, 2024, Nukkleus Inc., a company listed on the Nasdaq Stock Market, received a notification from Nasdaq's Listing Qualifications Department for non-compliance with the exchange's Listing Rule 5250(c)(1). The non-compliance issue arose due to Nukkleus Inc.'s failure to file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2024, in a timely manner. This notification is part of a series of warnings regarding the company's failure to meet certain listing requirements, including the Minimum Bid Price, Minimum Market Value of Publicly Held Shares, and Minimum Market Value of Listed Securities. Nukkleus Inc. has been given until July 29, 2024, to submit a compliance plan to Nasdaq and may receive an extension until November 11, 2024, to demonstrate compliance. The company is actively working to file the overdue Form 10-Q and regain compliance. Despite these notifications, the trading of Nukkleus Inc.'s common stock on the Nasdaq Global Market remains unaffected at this time.
2024年5月29日,在納斯達克股票市場上市的公司Nukkleus Inc. 因未遵守該交易所的上市規則5250(c)(1)而收到納斯達克上市資格部門的通知。違規問題是由於 Nukkleus Inc. 造成的。”未能及時提交截至2024年3月31日的季度10-Q表季度報告。該通知是有關公司未能滿足某些上市要求的一系列警告的一部分,包括最低出價、公開持有股票的最低市值和上市證券的最低市值。Nukkleus Inc.獲准在2024年7月29日之前向納斯達克提交合規計劃,並可能延長至2024年11月11日,以證明合規性。該公司正在積極努力提交逾期的10-Q表格,並恢復合規性。儘管有這些通知,但Nukkleus Inc.的交易仍在繼續。”目前,納斯達克全球市場上的普通股仍未受到影響。
2024年5月29日,在納斯達克股票市場上市的公司Nukkleus Inc. 因未遵守該交易所的上市規則5250(c)(1)而收到納斯達克上市資格部門的通知。違規問題是由於 Nukkleus Inc. 造成的。”未能及時提交截至2024年3月31日的季度10-Q表季度報告。該通知是有關公司未能滿足某些上市要求的一系列警告的一部分,包括最低出價、公開持有股票的最低市值和上市證券的最低市值。Nukkleus Inc.獲准在2024年7月29日之前向納斯達克提交合規計劃,並可能延長至2024年11月11日,以證明合規性。該公司正在積極努力提交逾期的10-Q表格,並恢復合規性。儘管有這些通知,但Nukkleus Inc.的交易仍在繼續。”目前,納斯達克全球市場上的普通股仍未受到影響。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。